Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results
- PMID: 14757616
- DOI: 10.7326/0003-4819-140-3-200402030-00009
Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results
Abstract
Background: The recent publication of clinical trial results has led to a dramatic shift in the evidence about postmenopausal hormone therapy.
Objective: To examine whether the publication of clinical trial results, specifically the Heart and Estrogen/progestin Replacement Study (HERS) in 1998 and the Women's Health Initiative (WHI) in 2002, has influenced the use of hormone therapy among postmenopausal women.
Design: Observational cohort (1997 to 2003).
Setting: San Francisco Mammography Registry, San Francisco, California.
Participants: Postmenopausal women between the ages of 50 and 74 years without a personal history of breast cancer who underwent mammography (151862 mammograms).
Measurements: Self-reported current use of hormone therapy.
Results: Among menopausal women who had mammography, it was estimated that 41% were currently using hormone therapy in 1997. Before the publication of HERS, the use of hormone therapy was increasing at a rate of 1% (95% CI, 0% to 2%) per quarter. After the publication of HERS, use decreased by 1% (CI, -3% to 0%) per quarter. In contrast, the publication of the WHI in 2002 was associated with a more substantial decline in the use of hormone therapy of 18% (CI, -21% to -16%) per quarter. Similar associations were observed for most subgroups of women, including women older than 65 years of age; women with a previous hysterectomy; and women who described their race or ethnicity as white, African American, Latina, Chinese, or Filipina.
Conclusions: The release of the HERS data was temporally associated with a modest decline in the use of hormone therapy. In contrast, the release of the principal findings from the WHI was associated with a more substantial decline in use by postmenopausal women. The reason for the differences in decline may relate to the fact that the WHI results were widely publicized or were more applicable to most postmenopausal women because the WHI study was performed in healthy women.
Comment in
-
The media matter: a call for straightforward medical reporting.Ann Intern Med. 2004 Feb 3;140(3):226-8. doi: 10.7326/0003-4819-140-3-200402030-00015. Ann Intern Med. 2004. PMID: 14757622 No abstract available.
-
Summaries for patients. Changes in the use of postmenopausal hormone replacement therapy after the publication of study results.Ann Intern Med. 2004 Feb 3;140(3):I50. doi: 10.7326/0003-4819-140-3-200402030-00004. Ann Intern Med. 2004. PMID: 14757633 No abstract available.
Similar articles
-
Summaries for patients. Changes in the use of postmenopausal hormone replacement therapy after the publication of study results.Ann Intern Med. 2004 Feb 3;140(3):I50. doi: 10.7326/0003-4819-140-3-200402030-00004. Ann Intern Med. 2004. PMID: 14757633 No abstract available.
-
Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.Exp Clin Endocrinol Diabetes. 2005 Oct;113(9):529-33. doi: 10.1055/s-2005-865802. Exp Clin Endocrinol Diabetes. 2005. PMID: 16235155
-
The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).J Womens Health (Larchmt). 2004 Nov;13(9):975-85. doi: 10.1089/jwh.2004.13.975. J Womens Health (Larchmt). 2004. PMID: 15665654
-
Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.Climacteric. 2003 May;6 Suppl 1:11-36. Climacteric. 2003. PMID: 12945798 Review.
-
New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.Maturitas. 2005 Sep 16;52(1):1-10. doi: 10.1016/j.maturitas.2005.05.003. Maturitas. 2005. PMID: 15963666 Review.
Cited by
-
The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study.PeerJ. 2016 Aug 24;4:e2374. doi: 10.7717/peerj.2374. eCollection 2016. PeerJ. 2016. PMID: 27635340 Free PMC article.
-
A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010.Obstet Gynecol. 2012 Sep;120(3):595-603. doi: 10.1097/AOG.0b013e318265df42. Obstet Gynecol. 2012. PMID: 22914469 Free PMC article.
-
Do we transfer health research results to people?Int J Prev Med. 2011 Apr;2(2):103-4. Int J Prev Med. 2011. PMID: 21603017 Free PMC article. No abstract available.
-
Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study.PLoS One. 2014 Jul 3;9(7):e101533. doi: 10.1371/journal.pone.0101533. eCollection 2014. PLoS One. 2014. PMID: 24992571 Free PMC article.
-
Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.Breast Cancer Res. 2007;9(6):R90. doi: 10.1186/bcr1839. Breast Cancer Res. 2007. PMID: 18162138 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical